Imricor Medical Systems, Inc. (ASX:IMR)
1.500
-0.030 (-1.96%)
Oct 17, 2025, 4:10 PM AEST
Imricor Medical Systems Revenue
Imricor Medical Systems had revenue of $196.88 thousand USD in the half year ending June 30, 2025, a decrease of -1.07%. This brings the company's revenue in the last twelve months to $748.54 thousand, down -9.19% year-over-year. In the year 2024, Imricor Medical Systems had annual revenue of $959.42 thousand with 55.86% growth.
Revenue (ttm)
$748.54K
Revenue Growth
-9.19%
P/S Ratio
421.46
Revenue / Employee
n/a
Employees
n/a
Market Cap
481.20M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 959.42K | 343.86K | 55.86% |
Dec 31, 2023 | 615.57K | -200.44K | -24.56% |
Dec 31, 2022 | 816.01K | 119.74K | 17.20% |
Dec 31, 2021 | 696.27K | -5.89K | -0.84% |
Dec 31, 2020 | 702.16K | 62.46K | 9.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Ramsay Health Care | 17.79B |
Sonic Healthcare | 9.65B |
Ansell | 3.06B |
Cochlear | 2.34B |
Regis Healthcare | 1.16B |
Telix Pharmaceuticals | 1.01B |
Neuren Pharmaceuticals | 218.86M |